The "off-label" role of recombinant factor VIIa in surgery: is the problem deficient evidence or defective concept?
Al-Ruzzeh
Sharif
S
Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA. sharifalruzzeh@hotmail.com
Navia
Jose L
JL
D016063:Blood Loss, Surgical / Q000517:prevention & control*; D006348:Cardiac Surgical Procedures / Q000379:methods; D003029:Coagulants / Q000494:pharmacology / Q000627:therapeutic use*; D004348:Drug Labeling; D015942:Factor VIIa / Q000494:pharmacology / Q000627:therapeutic use*; D006498:Hepatectomy / Q000379:methods; D006801:Humans; D016031:Liver Transplantation / Q000379:methods; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D013514:Surgical Procedures, Operative / Q000379:methods* / Q000639:trends; D014194:Traumatology / Q000379:methods
D003029:Coagulants; D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa